Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Eoganachton Mar 17, 2020 1:19am

74 Views

Post# 30815739

RE:RE:RE:RE:RE:RE:Trials

Hi Yajne - I think it was just a mistake as Hempdoc wrote.

Yajne wrote: Eogonaght, I kinda like that they've described the TLD-1433 as "systemic" which in my view might suggest it's "immuno" effects. not sure if that was their intent in using the word "systemic"

Bullboard Posts

Global Tungsten Market and Supply Security